Premium
Inhibition of interleukin‐1 release and activity by the rat seminal vesicle protein SV‐IV
Author(s) -
Vuotto Maria Luisa,
Peluso Gianfranco,
Mancino Domenico,
Colonna Giovanni,
Facchiano Antonio,
Lelpo Maria Teresa,
Ravagnan Giampietro,
Metafora Salvatore
Publication year - 1993
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1002/jlb.53.3.214
Subject(s) - biology , seminal vesicle , vesicle , medicine , endocrinology , microbiology and biotechnology , biochemistry , prostate , genetics , cancer , membrane
SV‐IV, a 9.8‐kd protein isolated from rat seminal vesicle secretion, has been shown to have strong non‐species‐specific immunosuppressive, anti‐inflammatory, antithrombotic, and antiphospholipase A2 properties. The present investigation was undertaken to determine the mechanism of action of its immunosuppressive effects. It was found that SV‐IV is a potent inhibitor of interleukin‐1 (EL‐1) release from lipopolysaccharide (LPS)‐activated human adherent monocytes and an effective inhibitor of ILrl‐induced thymocyte proliferation. The ability of SV‐IV to form a noncovalent dimeric association with IL‐lβ but not with IL‐lβ, its ability to induce a marked decrease of IL‐1 binding to its own receptors on the thymocyte surface, and its capacity to bind specifically to the macrophage plasma membrane might play an important role in the molecular mechanism of these inhibitory effects.